• Home
  • About
  • UPCOMING WEBINARS & SEMINARS
  • Consultation
  • USP 61/62 FAQ
  • Contact

Barry A. Friedman, PhD LLC

FDA Regulatory Compliance for the Pharmaceutical, Biotechnology and Medical Device Arenas

Upcoming Microbiological Webinars

July 31, 2020 By Barry Friedman Leave a Comment

Enclosed are a series of upcoming microbiological webinars which are being offered between now and the end of September.  While many of us are working from home or in the office on a limited basis, this represents a great opportunity to either gain new skills or refresh those that may require refreshing.  Just click on the title of each webinar to gain additional information or … [Read more...]

Microbiological Webinars

May 11, 2020 By Barry Friedman Leave a Comment

Enclosed are a series of upcoming microbiological related webinars which are being offered between now and the middle of June.  While many of us are working from home or in the office on a limited basis, this represents a great opportunity to either gain new skills or refresh those that may require refreshing.  Just click on the title of each webinar to gain … [Read more...]

Microbiological Webinars 2020 (Upcoming)

April 26, 2020 By Barry Friedman Leave a Comment

Enclosed are a series of upcoming microbiological related webinars which are being offered between now and the middle of June.  While many of us are working from home or in the office on a limited basis, this represents a great opportunity to either gain new skills or refresh those that may require refreshing.  Just click on the title of each webinar to gain … [Read more...]

General Chapter (USP<60>) on B. cepacia Complex to Issue December 1, 2019

February 19, 2019 By Barry Friedman Leave a Comment

Pharmacopeial Forum (PF, September/October 2018, 44(5)) published a new, proposed General Chapter (USP<60>) on B. cepacia Complex entitled “USP<60> Microbiological Examination of Nonsterile Products—Tests for Burkholderia cepacia Complex”.  The proposed PF chapter represents an expansion of USP<62> Microbiological Examination of Nonsterile Products: Tests for … [Read more...]

Les Produits Chimiques B.G.R., Inc. Receives FDA Warning Letter (07/24/2018) for Failure to Perform Laboratory Testing

August 15, 2018 By Barry Friedman Leave a Comment

Les Produits Chimiques B.G.R., Inc. Receives FDA Warning Letter (07/24/2018) for Failure to Perform Laboratory Testing.  The U.S. Food and Drug Administration (FDA) inspected Les Produits Chimiques B.G.R., Inc., Pointe-Claire, Quebec, from September 25 to 27, 2017.  A Warning Letter was issued which contained significant deviations from current good manufacturing practice … [Read more...]

Next Page »
New Reader? Learn More

Connect With Me:

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Webinar Registration & Information

FREQUENTLY ASKED QUESTIONS:

FDA Form 483 Frequently Asked Questions

USP General Chapter

USP General Chapter 62, Part II

TOP OBSERVATIONS:

FDA’s CDER LISTING OF TOP NINETEEN OBSERVATIONS FOR 2014

FDA CDER Most Frequent Form FDA 483 Observations Fiscal Year 2012

CDER MOST FREQUENTLY CITED DRUG OBSERVATIONS – FISCAL YEAR 2010

Top Posts:

Top Posts for 2012

Top Posts for 2013

Top Posts Year To Date

Recent Posts

  • Upcoming Microbiological Webinars
  • Microbiological Webinars
  • Microbiological Webinars 2020 (Upcoming)
  • General Chapter (USP<60>) on B. cepacia Complex to Issue December 1, 2019
  • Les Produits Chimiques B.G.R., Inc. Receives FDA Warning Letter (07/24/2018) for Failure to Perform Laboratory Testing

Categories

follow us in feedly
  • Home
  • About
  • UPCOMING WEBINARS & SEMINARS
  • Consultation
  • USP 61/62 FAQ
  • Contact
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Thank You For Visiting Barry A. Friedman, PhD LLC - 2015

Welcome To My Blog!
Please enter your name and email below to receive my newsletter.
Your information will *never* be shared or sold to a 3rd party.